Sanofi should hear from the FDA in September about its application for Sarclisa as a first-line therapy for multiple myeloma after the US regulator gave it a priority review. The French pharma group ...

Primary progressive multiple sclerosis (PPMS) symptoms usually worsen steadily over time, often without remission. It can be harder to diagnose than relapsing-remitting multiple sclerosis (RRMS). PPMS ...

Discover how the triple exponential average (TRIX) indicator serves as a momentum indicator by filtering out noise and offering insights into market trends.

Pew Research Center is a nonpartisan, nonadvocacy fact tank that informs the public about the issues, attitudes and trends shaping the world.